OpenVSafe by OpenVAERS
Search V-safe

ZR7-75880-00423

3 vaccinations 1 coded response 16 check-ins 1 free-text entry 0 call cases
Sex
Female
Age at first dose
12-15
ZIP prefix
181 / PA
Registered
2021-06-26
Relationship
Child or adolescent in my care
Guardian
FRC-91433-30827
Race
N/A
Ethnicity
N/A

Timeline

  1. 2021-06-03
    Dose 1 — Pfizer-BioNTech
  2. 2021-06-24
    Dose 2 — Pfizer-BioNTech
  3. 2021-06-26
    Registered in v-safe
  4. 2021-06-28
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  5. 2021-07-10
    Health check-in — day 14, dose 2, dependent
    Feeling: Good
    Adult check-in
  6. 2021-07-15
    Health check-in — day 21, dose 2, dependent
    Feeling: Good
    Adult check-in
  7. 2021-07-22
    Health check-in — day 28, dose 2, dependent
    Feeling: Good
    Adult check-in
  8. 2021-07-30
    Health check-in — day 35, dose 2, dependent
    Feeling: Good
    Adult check-in
  9. 2021-08-06
    Health check-in — day 42, dose 2, dependent
    Feeling: Good
    Adult check-in
  10. 2021-09-23
  11. 2021-12-23
  12. 2022-04-29
    Dose 3 — Pfizer-BioNTech
    Co-administered: HPV
  13. 2022-05-14
    Survey response — day 14, dose 3, dependent
    MedDRA: Cough, Rhinorrhoea, Secretion discharge — Feeling: Good · Be unable to work or attend school
    Free text: About a week after the shots she experienced excessive clear mucus flow from her nostrils. Then she had a cough that produced mucus. No fever or other symptoms that were troubling. This happened for a week or more. She recovered. Back to normal.
    MedDRA releases: 2024-11 · check-in free text available
  14. 2022-05-22
    Health check-in — day 21, dose 3, dependent
    Feeling: Fair
    Adult check-in
  15. 2022-05-27
    Health check-in — day 28, dose 3, dependent
    Feeling: Good
    Adult check-in
  16. 2022-06-03
    Health check-in — day 35, dose 3, dependent
    Feeling: Good
    Adult check-in
  17. 2022-06-10
    Health check-in — day 42, dose 3, dependent
    Feeling: Good
    Adult check-in
  18. 2022-07-29
  19. 2022-10-28
  20. 2023-04-29

Vaccinations

DoseDateManufacturerCo-administered
12021-06-03Pfizer-BioNTech No
22021-06-24Pfizer-BioNTech No
32022-04-29Pfizer-BioNTech HPV

Free text

Release 11 — day 14, dose 3, dependent

2022-05-14

Symptoms: About a week after the shots she experienced excessive clear mucus flow from her nostrils. Then she had a cough that produced mucus. No fever or other symptoms that were troubling. This happened for a week or more. She recovered. Back to normal.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDRhinorrhoea · · ✓
SDSecretion discharge · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release